Dry eye signs and symptoms in aromatase inhibitor treatment and the relationship with pain
- 1 January 2020
- journal article
- research article
- Published by Elsevier in The Ocular Surface
- Vol. 18 (1) , 108-113
Abstract
No abstract availableKeywords
Funding Information
- Faculty of Science, Monash University
This publication has 30 references indexed in Scilit:
- Efficacy of diagnostic criteria for the differential diagnosis between obstructive meibomian gland dysfunction and aqueous deficiency dry eyeJapanese Journal of Ophthalmology, 2010
- Proposed Diagnostic Criteria for Obstructive Meibomian Gland DysfunctionOphthalmology, 2009
- Meibomian Gland Diagnostic Expressibility: Correlation With Dry Eye Symptoms and Gland LocationCornea, 2008
- Marx Line: Fluorescein Staining Line on the Inner Lid as Indicator of Meibomian Gland FunctionAmerican Journal of Ophthalmology, 2006
- Regulation of Aromatase Expression in Estrogen-Responsive Breast and Uterine Disease: From Bench to TreatmentPharmacological Reviews, 2005
- Pharmacokinetics of third-generation aromatase inhibitorsSeminars in Oncology, 2003
- Is Complete Androgen Insensitivity Syndrome Associated with Alterations in the Meibomian Gland and Ocular Surface?Cornea, 2003
- Side effects of chemotherapeutic oculo-toxic agents: a reviewClinical Eye and Vision Care, 2000
- IntracrinologyMolecular and Cellular Endocrinology, 1991
- Meibomian gland disease. Classification and grading of lid changesEye, 1991